AXIN2 and breast adenocarcinoma: Ma et al. [37] showed that baicalein can inhibit the expression of Wnt1 and β-catenin in breast adenocarcinoma cells and decreased both the expression of Cyclin D1 and the core Axin2 expression at the level of transcription by dose and time.